Yeh Ming-Hsien, Chiu Hung-Pin, Wu Mei-Chun, Koo Malcolm, Lin Nai-Wei, Liao Kou-Kai, Yeh Chia-Chou, Li Te-Mao
Graduate Institute of Chinese Medicine, China Medical University, Taichung 40402, Taiwan.
Department of Chinese Medicine, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Dalin, Chiayi 62247, Taiwan.
Evid Based Complement Alternat Med. 2020 Jan 13;2020:4561040. doi: 10.1155/2020/4561040. eCollection 2020.
Recent studies suggested that Traditional Chinese Medicine could play a beneficial role in conventional cancer treatment. The aim of this retrospective cohort study was to investigate the effect of Chinese herbal medicine (CHM) combined with Western medicine on the survival of patients with colorectal cancer. A retrospective cohort study was conducted on patients with newly diagnosed colorectal cancer identified from the Dalin Tzu Chi Hospital Cancer Registry Database in 2004-2014. Combining with the medical records of the study hospital, patients were classified into CHM users and CHM nonusers. Kaplan-Meier analyses and Cox proportional hazards regression analyses were used to investigate the survival between CHM users and CHM nonusers. A total of 535 patients with colorectal cancer were included in the study with 147 of them were CHM users. The log-rank test for Kaplan-Meier survival curve revealed a statistically significant difference between the survival of CHM users and CHM nonusers (P=0.006). Results from multivariate Cox regression analysis showed that CHM use was significantly associated with better survival (adjusted hazard ratio = 0.54, 95% CI = 0.38 to 0.77). In addition, the CHM formulae Jia Wei Xiao Yao San, Zhi Bah Di Huang Wan, Ping Wei San, and Qui Pi Tang were significantly associated with better survival. In conclusion, findings from this retrospective cohort study indicated that integrated CHM and Western medicine could improve survival in patients with colorectal cancer. Additional research on integrating TCM with Western medicine to improve cancer survival is warranted.
近期研究表明,传统中医在常规癌症治疗中可能发挥有益作用。这项回顾性队列研究的目的是调查中药(CHM)联合西药对结直肠癌患者生存情况的影响。对2004年至2014年大林慈济医院癌症登记数据库中确诊的新发性结直肠癌患者进行了一项回顾性队列研究。结合研究医院的病历记录,将患者分为中药使用者和非使用者。采用Kaplan-Meier分析和Cox比例风险回归分析来研究中药使用者和非使用者之间的生存情况。该研究共纳入535例结直肠癌患者,其中147例为中药使用者。Kaplan-Meier生存曲线的对数秩检验显示,中药使用者和非使用者的生存情况存在统计学上的显著差异(P = 0.006)。多变量Cox回归分析结果表明,使用中药与更好的生存率显著相关(调整后的风险比 = 0.54,95%置信区间 = 0.38至0.77)。此外,中药方剂加味逍遥散、知柏地黄丸、平胃散和归脾汤与更好的生存率显著相关。总之,这项回顾性队列研究的结果表明,中西医结合可提高结直肠癌患者的生存率。有必要进一步开展关于中西医结合以提高癌症患者生存率的研究。